Aether FY26 Results: Growth Led by CEM and CRAMS as New Sites Ramp Up

Aether Industries ended FY26 with a clear step up in scale and profitability, with growth led by its contract-led businesses and supported by new capacity starting to come online. On a consolidated basis, revenue from operations rose to ₹11,601 million, up 38 percent year on year. EBITDA increased to ₹3,547 million, up 53 percent, and margins expanded to 31 percent from 28 percent in FY25. Profit after tax came in at ₹2,195 million, up 39 percent, with PAT margin improving to 19 percent from 18 percent.

The headline numbers matter, but the composition matters more. The company attributed performance to stronger traction in Contract Exclusive Manufacturing and Contract Research and Manufacturing Services, where customer stickiness is typically higher and pricing can be more resilient. FY26 also included early contributions from Site 3++, which commenced production toward the end of February and is now in ramp up mode.

In Q4 FY26, consolidated operating revenue was ₹3,051 million, up 27 percent year on year compared with ₹2,402 million in Q4 FY25. EBITDA for the quarter was ₹814 million, up 6 percent year on year, and PAT was ₹540 million, up 7 percent year on year. The quarter also carried specific, disclosed items that affected comparability, including loss of inventories from a fire at an external warehouse in March 2026 and certain year-end provisions. The company also noted inclusion of claim items within the quarter numbers.

Mix Shift: Contract Businesses Become the Core Story

FY26 showed a continued move toward higher contribution from CEM and CRAMS. In the company’s FY26 business model mix, CEM contributed 46 percent of revenue, CRAMS contributed 9 percent, Large Scale Manufacturing contributed 43 percent, and Others made up 1 percent. Management also highlighted that CEM and CRAMS together contribute more than 55 percent of revenue.

The quarterly trend points to the same direction. In Q4 FY26, CEM revenue was ₹1,632 million and represented 54 percent, up from ₹909 million and 38 percent in Q4 FY25. CRAMS was ₹291 million and represented 10 percent, broadly stable versus ₹244 million and 10 percent in Q4 FY25. Large Scale Manufacturing was ₹1,118 million and represented 37 percent, down from ₹1,230 million and 51 percent a year ago. This does not necessarily indicate weaker absolute demand for LSM over the full year, but it does show that contract-driven segments are growing faster and are taking a larger share of the quarterly mix.

The segment mix shift also showed up in profitability commentary. In Q4 FY26, the company pointed to improved profitability from a change in segment mix, and described EBITDA being led by CRAMS and CEM contracts. Even with quarter-specific impacts, FY26 full-year margin expansion suggests that operating leverage and better mix are starting to translate into sustained returns.

Financial summary (Consolidated)

End-market Rebalancing: Oil and Gas Up, Pharma Still Largest

Aether’s end-market exposure shifted meaningfully, both quarter on quarter and year on year. In Q4 FY26, pharma remained the largest segment at 34.0 percent of revenue, but its share was lower than 38.3 percent in Q4 FY25. The most striking change in the quarter was oil and gas, which rose to 23.9 percent from 13.7 percent a year ago. Material science represented 16.2 percent, down from 20.8 percent. Agro represented 10.8 percent, down from 17.2 percent. High performance photography rose to 5.6 percent from 1.5 percent, while coatings and sustainability and renewables stayed small.

Across the full year, the mix shift was even clearer. In FY26, pharma accounted for 34.2 percent compared with 45.6 percent in FY25. Oil and gas rose to 21.1 percent from 6.0 percent. Material science increased to 17.7 percent from 11.4 percent. Agro declined to 12.2 percent from 21.2 percent. Multiple was 6.2 percent versus 7.7 percent, high performance photography was 4.7 percent versus 3.3 percent, coatings was 2.8 percent versus 3.7 percent, and sustainability and renewables remained at 1.0 percent.

This rebalancing reduces concentration in any single end market and aligns with the company’s emphasis on diversified customer traction. It also fits the contract-led model. As CEM and CRAMS grow, the company’s revenue becomes more tied to specific customer programs rather than only commodity-like large-scale volumes.

Segment mix comparison (Revenue share)

Execution and Capacity: Site 3++ and Site 5 Set Up FY27

Aether’s operational narrative in FY26 was defined by commissioning and readiness. Site 3++ commenced production toward the end of February and is in ramp up mode. Management expects strategic supply to ramp up in Q1 FY27. This is important because the year-end start limits FY26 contribution but can meaningfully influence the FY27 run rate if yields, customer qualification, and scheduling progress as planned.

Site 5 is the next visible milestone. Phase one consists of two production blocks that are ready, with water and solvent trials begun. Commercial production is expected by Q1 FY27, and the company also stated that expansion of Phase 2 has commenced. For investors, the sequencing suggests a near-term start with a longer runway for incremental capacity additions.

The company also emphasized operational controls and customer readiness through its Accomplished 50 program, which included customer and certification audits in FY26. While this does not carry a direct number in the presentation, it supports the contract model because audit outcomes can be critical gating items for customer approvals and for moving from development to commercial volumes.

On the innovation side, Aether maintained a clear R and D-first framing. The company spent ₹862.13 million on R and D in FY26, which was 7.3 percent of revenue. Management also highlighted a tangible R and D expansion plan, with 18 fume hoods being installed in the current R and D set-up and a new R and D center being expanded on adjacent land. The longer trend in R and D intensity shows the company has sustained elevated spending since FY22, with 6.6 percent in FY22, 7.5 percent in FY23, 15.4 percent in FY24, and 7.7 percent in FY25.

Balance Sheet and Cash Flow: Capex Phase Visible in Cash and Borrowings

The FY26 cash flow statement shows a company still in a heavy investment cycle. Net cash generated from operating activities was ₹1,424 million, up from ₹1,000 million in FY25, reflecting higher earnings and operating scale. But investing cash outflow was large at ₹6,194 million versus ₹4,185 million in FY25, consistent with the ongoing site expansions.

Financing cash inflow was ₹2,439 million in FY26 compared with ₹13 million in FY25, and cash and cash equivalents closed at ₹57 million versus ₹2,385 million at the end of FY25. The decline in closing cash is therefore not explained by weaker operations, but by capex outpacing operating cash generation during the year.

The balance sheet reflects the same story. Consolidated property, plant and equipment increased to ₹12,362 million from ₹9,439 million, and capital work-in-progress rose to ₹5,061 million from ₹3,554 million, indicating assets still under construction and commissioning. On the liabilities side, consolidated current borrowings increased to ₹4,417 million from ₹1,825 million. Total assets rose to ₹32,014 million from ₹26,442 million, while total equity increased to ₹24,559 million from ₹22,259 million.

This balance sheet movement is typical when a manufacturer builds out new blocks and ramps up sites. The key variable to monitor in the next phase is whether new capacity translates into higher steady-state operating cash flow, which can then bring leverage and liquidity back to more comfortable levels without slowing growth.

Takeaways for Investors

FY26 was a year of both performance and positioning for Aether. The company delivered strong year-on-year growth in revenue, EBITDA, and PAT, alongside margin expansion, indicating that the contract-led mix is gaining traction. The quarterly mix suggests CEM has become the primary growth engine, while CRAMS remains steady and LSM has become a smaller share of the total.

At the same time, the company is still in a capex-heavy phase. The cash flow and rise in borrowings make that clear, but so does the visible pipeline of operational milestones: Site 3++ ramp up in early FY27 and Site 5 Phase 1 commercial production expected in June 2026, with broader commercialization by Q1 FY27 and Phase 2 expansion underway.

The theme emerging from the presentation is disciplined execution through a transition. Aether is scaling capacity, keeping R and D spending meaningful at 7.3 percent of revenue, and shifting revenue toward contract manufacturing models that can support margins. If commissioning timelines hold and mix trends persist, FY27 will be shaped less by building and more by converting new sites into sustained revenue and cash generation.